CLOBETASOL 0.05% + SALICYLIC ACID 6% Topical formulation is an innovative pharmaceutical combination containing two active pharmaceutical ingredients, Clobetasol and Salicylic Acid. This pharmaceutical combination is formulated as a semisolid, with ingredients distributed into a specific pharmaceutical vehicle to provide uniformity, consistency, and stability in the final product.
The formulation of CLOBETASOL 0.05% + SALICYLIC ACID 6% requires accurate measurement of the two active pharmaceutical ingredients in relation to the total amount of formulation in order to ensure reproducibility and compliance with specifications. Due to the difference in characteristics, compatibility and the ability of the pharmaceutical ingredients to disperse in the vehicle is a key consideration. Typical pharmaceutical vehicles used include cream, ointment, gel, or other semisolid bases. Often, the active pharmaceutical ingredients may be dissolved or dispersed uniformly as part of the development process prior to use as part of the final formulation.
Preformulation testing can be undertaken to examine the solubility of the two pharmaceutical ingredients in a range of pharmaceutical excipients. Determination of the particle size of each active prior to use can also provide important information. The formulation may incorporate emollients, solvents, humectants, thickening agents, stabilizers, preservatives, and other appropriate ingredients as needed.
The pH of the resulting formulation may be analyzed (where appropriate) along with the particle size distribution, drug content, appearance, color, physical stability, compatibility, and other parameters which can influence the stability and performance of the formulation.
Furthermore, the physical state (e.g., emulsified, partially emulsified, non-emulsified, etc.) and absorption/absorption rate of each active can be examined. The formulation may also be designed to incorporate additional standard excipients to provide optimal consistency, ease of use, and shelf-life properties.
Preparation of the semisolid formulation requires accurate weighing of each of the active ingredients (Clobetasol and Salicylic Acid). Starting materials are subjected to thorough inspections for appearance, identification, microbial limitations, and other quality parameters prior to incorporation.
The ingredients are then carefully dispensed from the bulk and into the formulation, often according to a master formulation. During the mixing process, the temperature is carefully controlled and mixing times are set and monitored to ensure adequate distribution of the active ingredients within the chosen pharmaceutical base. During this process, visual examination of the semi-solid may be undertaken to identify phase separation or other variations.
If necessary, the formulation may also undergo homogenization to ensure even and smooth distribution of the active ingredients across the product. Quality checks may include color, pH, viscosity, or content uniformity assessments. Once a homogeneous and appropriate formulation has been achieved, the bulk formulation may then be filled into the appropriate containers using suitable processing equipment.
Quality control of CLOBETASOL 0.05% + SALICYLIC ACID 6% involves evaluation of each of the active ingredients, as well as the physical characteristics of the finished semisolid formulation. Several tests are undertaken according to the previously described specifications and the relevant requirements.
The quality-control testings undertaken will include physical, chemical, microbiological, and homogeneity evaluations. Identification, assay, and related substance tests of the active pharmaceutical ingredients may also be performed. Due to the low concentration of Clobetasol, it may be necessary to perform more sensitive analytic techniques for this parameter. Physical evaluations may include color, smell, consistency, stickiness, or phase separation.
Microscopic examinations or visual assessments may also be undertaken to evaluate the dispersal of solid particles within the semisolid vehicle. Microbiological examination and testing (if the formulation contains an aqueous component) can also be incorporated within the quality assurance system. This involves specifications around the growth and identification of potentially pathogenic organisms as well as specifications around the preservative system.
Additional factors considered as part of the quality assurance system may include equipment calibration and validation, sampling, testing, environmental monitoring, documentation, data review, deviation and change management, and batch release criteria.
Stability studies are an important component of any pharmaceutical development program. They involve examining the final formulation of the pharmaceutical preparation after storage over a period of time at designated storage conditions (temperatures, humidity, and light).
If the formulation is intended to be stored in a tube, tubette, or other container-closure system, the packaging can influence the stability of the active components. The formulation may be stored in plastic or aluminum tubes, laminated or plastic syringes, or other appropriate secondary containers. The formulation may also be stored in a variety of different process container sizes to analyze fill-weight deviations during the manufacturing process.
The content of the formulation may also influence the formulation stability. It is advisable to select the final container and bagging system during the formulation development process. Additionally, the stability of the formulation will be assessed by visual analysis, appearance, and composition of the semisolid within the selected container. Any differences in odor or consistency may be noted and relevant documentation maintained.
Application of the formulation to the packaging system should also be consistent, predictable, and repeatable, with examination undertaken during the filling and sealing process for visual consistency and fill volume consistency.
Stability samples may also be visually examined for color, phase separation, and appearance of foreign bodies during storage. The physical and chemical stability may also be tested at regular intervals.
A well-established pharmaceutical formulation system comprises the interaction of the active constituents, the formulation process, the selection of suitable packaging, and the label indicating the following: pharmaceutical composition, ingredients list, directions, batch identification, and a storage statement.
We combine quality, innovation, and strong distribution to help our partners grow successfully in the pharma market.
The company is offering business opportunity for scalable and sustainable returns to its associates. We are engaged in discovery, development and commercialization of pharmaceutical medicine keeping in mind its quality and affordability.
© Novolilly 2025. All Rights Reserved – Developed & Managed By Kavir Infotech